专利检索 ap:("UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION") AND inv:"Justin R. NICKELL" 第 1 页

1.

发明申请
1,4-Disubstituted Piperidines, 1,4-Disubstituted Piperazines, 1,4-Disubstituted Diazepines, and 1,3-Disubstituted Pyrrolidine Compounds 审中-公开

公开(公告)号：US20170226072A1

公开(公告)日：2017-08-10

申请号：US15494789

申请日：2017-04-24

申请人： University of Kentucky Research Foundation

发明人： Peter A. CROOKS , Linda P. DWOSKIN , John CULVER , Justin R. NICKELL , Guangrong ZHENG

IPC分类号： C07D295/096 , C07D295/073 , C07D211/22 , C07D211/18 , C07D211/14 , C07D295/03

CPC分类号： C07D295/096 , C07D211/08 , C07D211/14 , C07D211/18 , C07D211/22 , C07D295/02 , C07D295/03 , C07D295/073

摘要： The present invention is directed to 1,4-disubstituted piperidines, 1,4-disubstituted piperazines, 1,4-disubstituted diazepanes, and 1,3-disubstituted pyrrolidine compounds and their use.

2.

发明申请
Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse 审中-公开

公开(公告)号：US20170304227A1

公开(公告)日：2017-10-26

申请号：US15493836

申请日：2017-04-21

申请人： University of Kentucky Research Foundation

发明人： Linda DWOSKIN , Peter Anthony CROOKS , Guangrong ZHENG , Justin R. NICKELL , Zheng CAO , Na-Ra LEE

IPC分类号： A61K31/137

CPC分类号： A61K31/137 , A61K31/138

摘要： The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.

3.

发明申请
VESICULAR MONOAMINE TRANSPORTER-2 LIGANDS AND THEIR USE IN THE TREATMENT OF PSYCHOSTIMULANT ABUSE 审中-公开

公开(公告)号：US20200237688A1

公开(公告)日：2020-07-30

申请号：US16846989

申请日：2020-04-13

申请人： University of Kentucky Research Foundation

发明人： Linda P. DWOSKIN , Peter Anthony CROOKS , Guangrong ZHENG , Justin R. NICKELL , Zheng CAO , Na-Ra LEE

IPC分类号： A61K31/137 , A61K31/138

摘要： The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.

4.

发明申请
1,4-Disubstituted Piperidines, 1,4-Disubstituted Piperazines, 1,4-Disubstituted Diazepines, and 1,3-Disubstituted Pyrrolidine Compounds 审中-公开
标题翻译： 1,4-二取代哌啶，1,4-二取代哌嗪，1,4-二取代二氮杂和1,3-二取代吡咯烷化合物

公开(公告)号：US20160031840A1

公开(公告)日：2016-02-04

申请号：US14776306

申请日：2014-03-14

申请人： UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION

发明人： Peter A. CROOKS , Linda P. DWOSKIN , John CULVER , Justin R. NICKELL , Guangrong ZHENG

IPC分类号： C07D295/03 , C07D211/08

CPC分类号： C07D295/096 , C07D211/08 , C07D211/14 , C07D211/18 , C07D211/22 , C07D295/02 , C07D295/03 , C07D295/073

摘要： The present invention is directed to 1,4-disubstituted piperidines, 1,4-disubstituted piperazines, 1,4-disubstituted diazepanes, and 1,3-disubstituted pyrrolidine compounds and their use.

摘要翻译： 本发明涉及1,4-二取代的哌啶，1,4-二取代的哌嗪，1,4-二取代的二氮杂环庚烷和1,3-二取代的吡咯烷化合物及其用途。